APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artificial Blood Products Market Analysis and Forecast 2026-2032

30 December 2025190 pages

Choose your research edition.

Industry ResearchArtificial Blood Products Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Products Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Artificial Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Products Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Artificial Blood Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Artificial Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Artificial Blood Products include SpheriTech Ltd., NuvOx Pharma, KaloCyte Inc., HEMARINA SA, HbO2 Therapeutics and Aurum Biosciences Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Artificial Blood Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Blood Products, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Blood Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Artificial Blood Products sales, projected growth trends, production technology, application and end-user industry.

Artificial Blood Products Segment by Company

SpheriTech Ltd.

NuvOx Pharma

KaloCyte Inc.

HEMARINA SA

HbO2 Therapeutics

Aurum Biosciences Ltd.

Artificial Blood Products Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Products Segment by Application

Military

Civil

Artificial Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Artificial Blood Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Blood Products sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Blood Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Perfluorocarbon-based Oxygen Carrier (PFBOC) Major Manufacturers Table 3. Hemoglobin-based Oxygen Carrier (HBOC) Major Manufacturers Table 4. Global Artificial Blood Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Military Major Manufacturers Table 6. Civil Major Manufacturers Table 7. Artificial Blood Products Industry Trends Table 8. Artificial Blood Products Industry Drivers Table 9. Artificial Blood Products Industry Opportunities and Challenges Table 10. Artificial Blood Products Industry Restraints Table 11. Global Artificial Blood Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Artificial Blood Products Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Artificial Blood Products Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Artificial Blood Products Revenue Market Share by Region (2021-2026) Table 15. Global Artificial Blood Products Revenue Market Share by Region (2027-2032) Table 16. Global Artificial Blood Products Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Artificial Blood Products Sales by Region (2021-2026) & (K Units) Table 18. Global Artificial Blood Products Sales by Region (2027-2032) & (K Units) Table 19. Global Artificial Blood Products Sales Market Share by Region (2021-2026) Table 20. Global Artificial Blood Products Sales Market Share by Region (2027-2032) Table 21. Global Artificial Blood Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Artificial Blood Products Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Artificial Blood Products Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Artificial Blood Products Sales Market Share by Manufacturers (2021-2026) Table 25. Global Artificial Blood Products Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Artificial Blood Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Artificial Blood Products Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Artificial Blood Products Manufacturers, Product Type & Application Table 29. Global Artificial Blood Products Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Artificial Blood Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Artificial Blood Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Artificial Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Artificial Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Artificial Blood Products Revenue Market Share by Type (2021-2026) Table 36. Global Artificial Blood Products Revenue Market Share by Type (2027-2032) Table 37. Global Artificial Blood Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 39. Global Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 40. Global Artificial Blood Products Sales Market Share by Type (2021-2026) Table 41. Global Artificial Blood Products Sales Market Share by Type (2027-2032) Table 42. Global Artificial Blood Products Price by Type (2021-2026) & (US$/Unit) Table 43. Global Artificial Blood Products Price by Type (2027-2032) & (US$/Unit) Table 44. Global Artificial Blood Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Artificial Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Artificial Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Artificial Blood Products Revenue Market Share by Application (2021-2026) Table 48. Global Artificial Blood Products Revenue Market Share by Application (2027-2032) Table 49. Global Artificial Blood Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 51. Global Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 52. Global Artificial Blood Products Sales Market Share by Application (2021-2026) Table 53. Global Artificial Blood Products Sales Market Share by Application (2027-2032) Table 54. Global Artificial Blood Products Price by Application (2021-2026) & (US$/Unit) Table 55. Global Artificial Blood Products Price by Application (2027-2032) & (US$/Unit) Table 56. SpheriTech Ltd. Company Information Table 57. SpheriTech Ltd. Business Overview Table 58. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. SpheriTech Ltd. Artificial Blood Products Product Portfolio Table 60. SpheriTech Ltd. Recent Development Table 61. NuvOx Pharma Company Information Table 62. NuvOx Pharma Business Overview Table 63. NuvOx Pharma Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. NuvOx Pharma Artificial Blood Products Product Portfolio Table 65. NuvOx Pharma Recent Development Table 66. KaloCyte Inc. Company Information Table 67. KaloCyte Inc. Business Overview Table 68. KaloCyte Inc. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. KaloCyte Inc. Artificial Blood Products Product Portfolio Table 70. KaloCyte Inc. Recent Development Table 71. HEMARINA SA Company Information Table 72. HEMARINA SA Business Overview Table 73. HEMARINA SA Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. HEMARINA SA Artificial Blood Products Product Portfolio Table 75. HEMARINA SA Recent Development Table 76. HbO2 Therapeutics Company Information Table 77. HbO2 Therapeutics Business Overview Table 78. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. HbO2 Therapeutics Artificial Blood Products Product Portfolio Table 80. HbO2 Therapeutics Recent Development Table 81. Aurum Biosciences Ltd. Company Information Table 82. Aurum Biosciences Ltd. Business Overview Table 83. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio Table 85. Aurum Biosciences Ltd. Recent Development Table 86. North America Artificial Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Artificial Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 89. North America Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 90. North America Artificial Blood Products Sales Price by Type (2021-2026) & (US$/Unit) Table 91. North America Artificial Blood Products Sales Price by Type (2027-2032) & (US$/Unit) Table 92. North America Artificial Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Artificial Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 95. North America Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 96. North America Artificial Blood Products Sales Price by Application (2021-2026) & (US$/Unit) Table 97. North America Artificial Blood Products Sales Price by Application (2027-2032) & (US$/Unit) Table 98. North America Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Artificial Blood Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Artificial Blood Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 102. North America Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 103. North America Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 104. North America Artificial Blood Products Sales Price by Country (2021-2026) & (US$/Unit) Table 105. North America Artificial Blood Products Sales Price by Country (2027-2032) & (US$/Unit) Table 106. United States Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 107. Canada Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 108. Europe Artificial Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Artificial Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 111. Europe Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 112. Europe Artificial Blood Products Sales Price by Type (2021-2026) & (US$/Unit) Table 113. Europe Artificial Blood Products Sales Price by Type (2027-2032) & (US$/Unit) Table 114. Europe Artificial Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Artificial Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 117. Europe Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 118. Europe Artificial Blood Products Sales Price by Application (2021-2026) & (US$/Unit) Table 119. Europe Artificial Blood Products Sales Price by Application (2027-2032) & (US$/Unit) Table 120. Europe Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Artificial Blood Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. Europe Artificial Blood Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. Europe Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 124. Europe Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 125. Europe Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 126. Europe Artificial Blood Products Sales Price by Country (2021-2026) & (US$/Unit) Table 127. Europe Artificial Blood Products Sales Price by Country (2027-2032) & (US$/Unit) Table 128. Germany Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 129. France Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 130. U.K. Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 131. Italy Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 132. Netherlands Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 133. China Artificial Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 134. China Artificial Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 135. China Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 136. China Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 137. China Artificial Blood Products Sales Price by Type (2021-2026) & (US$/Unit) Table 138. China Artificial Blood Products Sales Price by Type (2027-2032) & (US$/Unit) Table 139. China Artificial Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 140. China Artificial Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 141. China Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 142. China Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 143. China Artificial Blood Products Sales Price by Application (2021-2026) & (US$/Unit) Table 144. China Artificial Blood Products Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Artificial Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Artificial Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 148. Asia Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 149. Asia Artificial Blood Products Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Asia Artificial Blood Products Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Asia Artificial Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 152. Asia Artificial Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 154. Asia Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 155. Asia Artificial Blood Products Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Asia Artificial Blood Products Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Artificial Blood Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Asia Artificial Blood Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Asia Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 161. Asia Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 162. Asia Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 163. Asia Artificial Blood Products Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Asia Artificial Blood Products Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Japan Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 166. South Korea Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 167. India Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 168. Australia Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 169. China Taiwan Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 170. Southeast Asia Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 171. SAMEA Artificial Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 172. SAMEA Artificial Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 173. SAMEA Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 174. SAMEA Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 175. SAMEA Artificial Blood Products Sales Price by Type (2021-2026) & (US$/Unit) Table 176. SAMEA Artificial Blood Products Sales Price by Type (2027-2032) & (US$/Unit) Table 177. SAMEA Artificial Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 178. SAMEA Artificial Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 179. SAMEA Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 180. SAMEA Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 181. SAMEA Artificial Blood Products Sales Price by Application (2021-2026) & (US$/Unit) Table 182. SAMEA Artificial Blood Products Sales Price by Application (2027-2032) & (US$/Unit) Table 183. SAMEA Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. SAMEA Artificial Blood Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. SAMEA Artificial Blood Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. SAMEA Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. SAMEA Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 188. SAMEA Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 189. SAMEA Artificial Blood Products Sales Price by Country (2021-2026) & (US$/Unit) Table 190. SAMEA Artificial Blood Products Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Brazil Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 192. Argentina Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 193. Chile Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 194. Colombia Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 195. Peru Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 196. Saudi Arabia Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 197. Israel Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 198. UAE Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 199. Turkey Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 200. Iran Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 201. Egypt Artificial Blood Products Revenue (2021-2032) & (US$ Million) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Artificial Blood Products Distributors List Table 205. Artificial Blood Products Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Artificial Blood Products Image Figure 2. Global Artificial Blood Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Blood Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 6. Global Artificial Blood Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Artificial Blood Products Market Size Share 2021 VS 2025 VS 2032 Figure 8. Military Image Figure 9. Civil Image Figure 10. Global Artificial Blood Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Artificial Blood Products Revenue (2021-2032) & (US$ Million) Figure 12. Global Artificial Blood Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Artificial Blood Products Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Artificial Blood Products Revenue Market Share by Region (2021-2032) Figure 15. Global Artificial Blood Products Sales (2021-2032) & (K Units) Figure 16. Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Artificial Blood Products Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Artificial Blood Products Sales YoY (2021-2032) & (K Units) Figure 19. Europe Artificial Blood Products Sales YoY (2021-2032) & (K Units) Figure 20. China Artificial Blood Products Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Artificial Blood Products Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Artificial Blood Products Sales YoY (2021-2032) & (K Units) Figure 23. Global Artificial Blood Products Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Artificial Blood Products Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Artificial Blood Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Artificial Blood Products Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Artificial Blood Products Revenue Market Share by Type (2021-2032) Figure 29. Global Artificial Blood Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Artificial Blood Products Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Artificial Blood Products Sales Market Share by Type (2021-2032) Figure 32. Global Artificial Blood Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Artificial Blood Products Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Artificial Blood Products Revenue Market Share by Application (2021-2032) Figure 35. Global Artificial Blood Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Artificial Blood Products Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Artificial Blood Products Sales Market Share by Application (2021-2032) Figure 38. North America Artificial Blood Products Revenue Share by Type (2021-2032) Figure 39. North America Artificial Blood Products Sales Share by Type (2021-2032) Figure 40. North America Artificial Blood Products Revenue Share by Application (2021-2032) Figure 41. North America Artificial Blood Products Sales Share by Application (2021-2032) Figure 42. North America Artificial Blood Products Revenue Share by Country (2021-2032) Figure 43. North America Artificial Blood Products Sales Share by Country (2021-2032) Figure 44. Europe Artificial Blood Products Revenue Share by Type (2021-2032) Figure 45. Europe Artificial Blood Products Sales Share by Type (2021-2032) Figure 46. Europe Artificial Blood Products Revenue Share by Application (2021-2032) Figure 47. Europe Artificial Blood Products Sales Share by Application (2021-2032) Figure 48. Europe Artificial Blood Products Revenue Share by Country (2021-2032) Figure 49. Europe Artificial Blood Products Sales Share by Country (2021-2032) Figure 50. China Artificial Blood Products Revenue Share by Type (2021-2032) Figure 51. China Artificial Blood Products Sales Share by Type (2021-2032) Figure 52. China Artificial Blood Products Revenue Share by Application (2021-2032) Figure 53. China Artificial Blood Products Sales Share by Application (2021-2032) Figure 54. Asia Artificial Blood Products Revenue Share by Type (2021-2032) Figure 55. Asia Artificial Blood Products Sales Share by Type (2021-2032) Figure 56. Asia Artificial Blood Products Revenue Share by Application (2021-2032) Figure 57. Asia Artificial Blood Products Sales Share by Application (2021-2032) Figure 58. Asia Artificial Blood Products Revenue Share by Country (2021-2032) Figure 59. Asia Artificial Blood Products Sales Share by Country (2021-2032) Figure 60. SAMEA Artificial Blood Products Revenue Share by Type (2021-2032) Figure 61. SAMEA Artificial Blood Products Sales Share by Type (2021-2032) Figure 62. SAMEA Artificial Blood Products Revenue Share by Application (2021-2032) Figure 63. SAMEA Artificial Blood Products Sales Share by Application (2021-2032) Figure 64. SAMEA Artificial Blood Products Revenue Share by Country (2021-2032) Figure 65. SAMEA Artificial Blood Products Sales Share by Country (2021-2032) Figure 66. Artificial Blood Products Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Artificial Blood Products Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • SpheriTech Ltd.
  • NuvOx Pharma
  • KaloCyte Inc.
  • HEMARINA SA
  • HbO2 Therapeutics
  • Aurum Biosciences Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Blood Products Market by Type
  3. 1.2.1 Global Artificial Blood Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  5. 1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
  6. 1.3 Artificial Blood Products Market by Application
  7. 1.3.1 Global Artificial Blood Products Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Military
  9. 1.3.3 Civil
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Artificial Blood Products Market Dynamics
  1. 2.1 Artificial Blood Products Industry Trends
  2. 2.2 Artificial Blood Products Industry Drivers
  3. 2.3 Artificial Blood Products Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Products Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Artificial Blood Products Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Artificial Blood Products Revenue by Region
  3. 3.2.1 Global Artificial Blood Products Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Blood Products Revenue by Region (2021-2026)
  5. 3.2.3 Global Artificial Blood Products Revenue by Region (2027-2032)
  6. 3.2.4 Global Artificial Blood Products Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Artificial Blood Products Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Artificial Blood Products Sales by Region
  9. 3.4.1 Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Artificial Blood Products Sales by Region (2021-2026)
  11. 3.4.3 Global Artificial Blood Products Sales by Region (2027-2032)
  12. 3.4.4 Global Artificial Blood Products Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Artificial Blood Products Revenue by Manufacturers
  2. 4.1.1 Global Artificial Blood Products Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Artificial Blood Products Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Artificial Blood Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Blood Products Sales by Manufacturers
  6. 4.2.1 Global Artificial Blood Products Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Artificial Blood Products Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Artificial Blood Products Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Artificial Blood Products Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Artificial Blood Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Artificial Blood Products Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Artificial Blood Products Manufacturers, Product Type & Application
  13. 4.7 Global Artificial Blood Products Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Artificial Blood Products Market CR5 and HHI
  16. 4.8.2 2025 Artificial Blood Products Tier 1, Tier 2, and Tier 3
5 Artificial Blood Products Market by Type
  1. 5.1 Global Artificial Blood Products Revenue by Type
  2. 5.1.1 Global Artificial Blood Products Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Artificial Blood Products Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Artificial Blood Products Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Artificial Blood Products Sales by Type
  6. 5.2.1 Global Artificial Blood Products Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artificial Blood Products Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Artificial Blood Products Sales Market Share by Type (2021-2032)
  9. 5.3 Global Artificial Blood Products Price by Type
6 Artificial Blood Products Market by Application
  1. 6.1 Global Artificial Blood Products Revenue by Application
  2. 6.1.1 Global Artificial Blood Products Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Artificial Blood Products Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Artificial Blood Products Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Artificial Blood Products Sales by Application
  6. 6.2.1 Global Artificial Blood Products Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Artificial Blood Products Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Artificial Blood Products Sales Market Share by Application (2021-2032)
  9. 6.3 Global Artificial Blood Products Price by Application
7 Company Profiles
  1. 7.1 SpheriTech Ltd.
  2. 7.1.1 SpheriTech Ltd. Company Information
  3. 7.1.2 SpheriTech Ltd. Business Overview
  4. 7.1.3 SpheriTech Ltd. Artificial Blood Products Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SpheriTech Ltd. Artificial Blood Products Product Portfolio
  6. 7.1.5 SpheriTech Ltd. Recent Developments
  7. 7.2 NuvOx Pharma
  8. 7.2.1 NuvOx Pharma Company Information
  9. 7.2.2 NuvOx Pharma Business Overview
  10. 7.2.3 NuvOx Pharma Artificial Blood Products Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 NuvOx Pharma Artificial Blood Products Product Portfolio
  12. 7.2.5 NuvOx Pharma Recent Developments
  13. 7.3 KaloCyte Inc.
  14. 7.3.1 KaloCyte Inc. Company Information
  15. 7.3.2 KaloCyte Inc. Business Overview
  16. 7.3.3 KaloCyte Inc. Artificial Blood Products Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 KaloCyte Inc. Artificial Blood Products Product Portfolio
  18. 7.3.5 KaloCyte Inc. Recent Developments
  19. 7.4 HEMARINA SA
  20. 7.4.1 HEMARINA SA Company Information
  21. 7.4.2 HEMARINA SA Business Overview
  22. 7.4.3 HEMARINA SA Artificial Blood Products Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 HEMARINA SA Artificial Blood Products Product Portfolio
  24. 7.4.5 HEMARINA SA Recent Developments
  25. 7.5 HbO2 Therapeutics
  26. 7.5.1 HbO2 Therapeutics Company Information
  27. 7.5.2 HbO2 Therapeutics Business Overview
  28. 7.5.3 HbO2 Therapeutics Artificial Blood Products Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HbO2 Therapeutics Artificial Blood Products Product Portfolio
  30. 7.5.5 HbO2 Therapeutics Recent Developments
  31. 7.6 Aurum Biosciences Ltd.
  32. 7.6.1 Aurum Biosciences Ltd. Company Information
  33. 7.6.2 Aurum Biosciences Ltd. Business Overview
  34. 7.6.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio
  36. 7.6.5 Aurum Biosciences Ltd. Recent Developments
8 North America
  1. 8.1 North America Artificial Blood Products Market Size by Type
  2. 8.1.1 North America Artificial Blood Products Revenue by Type (2021-2032)
  3. 8.1.2 North America Artificial Blood Products Sales by Type (2021-2032)
  4. 8.1.3 North America Artificial Blood Products Price by Type (2021-2032)
  5. 8.2 North America Artificial Blood Products Market Size by Application
  6. 8.2.1 North America Artificial Blood Products Revenue by Application (2021-2032)
  7. 8.2.2 North America Artificial Blood Products Sales by Application (2021-2032)
  8. 8.2.3 North America Artificial Blood Products Price by Application (2021-2032)
  9. 8.3 North America Artificial Blood Products Market Size by Country
  10. 8.3.1 North America Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Artificial Blood Products Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Artificial Blood Products Market Size by Type
  2. 9.1.1 Europe Artificial Blood Products Revenue by Type (2021-2032)
  3. 9.1.2 Europe Artificial Blood Products Sales by Type (2021-2032)
  4. 9.1.3 Europe Artificial Blood Products Price by Type (2021-2032)
  5. 9.2 Europe Artificial Blood Products Market Size by Application
  6. 9.2.1 Europe Artificial Blood Products Revenue by Application (2021-2032)
  7. 9.2.2 Europe Artificial Blood Products Sales by Application (2021-2032)
  8. 9.2.3 Europe Artificial Blood Products Price by Application (2021-2032)
  9. 9.3 Europe Artificial Blood Products Market Size by Country
  10. 9.3.1 Europe Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Artificial Blood Products Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Artificial Blood Products Market Size by Type
  2. 10.1.1 China Artificial Blood Products Revenue by Type (2021-2032)
  3. 10.1.2 China Artificial Blood Products Sales by Type (2021-2032)
  4. 10.1.3 China Artificial Blood Products Price by Type (2021-2032)
  5. 10.2 China Artificial Blood Products Market Size by Application
  6. 10.2.1 China Artificial Blood Products Revenue by Application (2021-2032)
  7. 10.2.2 China Artificial Blood Products Sales by Application (2021-2032)
  8. 10.2.3 China Artificial Blood Products Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Blood Products Market Size by Type
  2. 11.1.1 Asia Artificial Blood Products Revenue by Type (2021-2032)
  3. 11.1.2 Asia Artificial Blood Products Sales by Type (2021-2032)
  4. 11.1.3 Asia Artificial Blood Products Price by Type (2021-2032)
  5. 11.2 Asia Artificial Blood Products Market Size by Application
  6. 11.2.1 Asia Artificial Blood Products Revenue by Application (2021-2032)
  7. 11.2.2 Asia Artificial Blood Products Sales by Application (2021-2032)
  8. 11.2.3 Asia Artificial Blood Products Price by Application (2021-2032)
  9. 11.3 Asia Artificial Blood Products Market Size by Country
  10. 11.3.1 Asia Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Artificial Blood Products Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Blood Products Market Size by Type
  2. 12.1.1 SAMEA Artificial Blood Products Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Artificial Blood Products Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Artificial Blood Products Price by Type (2021-2032)
  5. 12.2 SAMEA Artificial Blood Products Market Size by Application
  6. 12.2.1 SAMEA Artificial Blood Products Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Artificial Blood Products Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Artificial Blood Products Price by Application (2021-2032)
  9. 12.3 SAMEA Artificial Blood Products Market Size by Country
  10. 12.3.1 SAMEA Artificial Blood Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Artificial Blood Products Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Artificial Blood Products Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Artificial Blood Products Value Chain Analysis
  2. 13.1.1 Artificial Blood Products Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Artificial Blood Products Production Mode & Process
  6. 13.2 Artificial Blood Products Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Artificial Blood Products Distributors
  9. 13.2.3 Artificial Blood Products Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst